Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3930667 | 0.99 | ESR2 (0.68) | ESR2ESR1 | |
| SCHEMBL4733695 | 0.98 | ESR2 (0.67) | ESR2ESR1 | |
| SCHEMBL3925626 | 0.88 | ESR2 (0.66) | ESR2ESR1 | |
| SCHEMBL14170020 | 0.86 | ESR2 (0.51) | ESR2ESR1 | |
| SCHEMBL4077806 | 0.84 | ESR2 (0.70) | ESR2ESR1 | |
| SCHEMBL3930802 | 0.84 | ESR2 (0.69) | ESR2ESR1 | |
| SCHEMBL2401903 | 0.83 | ESR2 (0.68) | ESR2ESR1 | |
| SCHEMBL3924579 | 0.83 | ESR2 (0.48) | ESR2ESR1 | |
| SCHEMBL4736120 | 0.81 | ESR2 (0.68) | ESR2ESR1 | |
| SCHEMBL12266867 | 0.81 | ESR2 (0.68) | ESR2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080139819-A1 | Process for the Synthesis of Monosulfated Derivatives of Substituted Benzoxazoles | WYETH (US) | 2008-06-12 | — | — | US | disclosed |
| WO-2008067425-A1 | PROCESS FOR THE SYNTHESIS OF MONOSULFATED DERIVATIVES OF SUBSTITUTED BENZOXAZOLES | WYETH (US) | 2008-06-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139819-A1 | Process for the Synthesis of Monosulfated Derivatives of Substituted Benzoxazoles | SULT1A1, STS, SULT2A1 | ESR2 10/4885ESR1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.